Last reviewed · How we verify
NCT05889806
AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)
trial testing Observational Study Only. NO Intervention. in Oncology in 10,000 participants. Enrolling by invitation.
10 May 2043
Quick facts
| Lead sponsor | Audubon Bioscience |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 10,000 |
| Start date | 10 May 2023 |
| Primary completion | 10 May 2043 |
| Estimated completion | 10 June 2043 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Observational Study Only. NO Intervention.
Conditions studied
- Oncology — all drugs for Oncology →
- Hematologic Malignancy — all drugs for Hematologic Malignancy →
- Gastro-Intestinal Disorder — all drugs for Gastro-Intestinal Disorder →
- Autoimmune Diseases — all drugs for Autoimmune Diseases →
Sponsor
Audubon Bioscience
Who can join
18 and older, any sex, with Oncology or Hematologic Malignancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study purpose: to explore the entire spectrum of proteomic and genomic changes (amongst others) involved in diseases and in healthy/control populations. The Study is designed to discover biomarkers, develop and validate diagnostic assays, instruments and therapeutics as well as other medical research. Specifically, researchers may analyze proteins, RNA, DNA copy number changes, including large and small (1,000-100,000 kb) scale rearrangements, transcription profiles, epigenetic modifications, sequence variation, and sequence in both diseased tissue and case-matched germline DNA from Subjects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05889806
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Oncology
Currently open trials in the same condition.
- NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
- NCT07262632 — Developing a Multimodal Cancer Pain Database to Support AI-Based Automatic Pain Assessment · recruiting
- NCT06868524 — Leading Healthy Eating and Activity Promotion Program · NA · recruiting
- NCT06959810 — Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management · NA · recruiting
- NCT06950073 — Curatively Intended Thoracic Reirradiation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05889806 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Audubon Bioscience
- Last refreshed: 5 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05889806.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing